by • May 4, 2016 • No Comments
There’s no denying that 3D printing innovation is steadily changing the shape of the medical industry, whether it be through anatomical models, guides, implants, or the many other applications that go on to become additional widely accepted and utilized in healthcare services across the world. One of the top providers of the healthcare-driven 3D printing revolution is the Leuven, Belgium-based Materialise NV. Focutilized on academia, medical device companies, and the hospital environment, Materialise has gained really a stronghold on the medical industry over the past few years.
Last year, we covered the service bureau’s partnership with medical product turn it intoment company Kapstone Medical, as well as a five-year deal with Japan’s Medical Dynamic Marketing, Inc., who partnered with Materialise for 3D printed hip replacements. Their biomedical software, called the Mimics Innovation Suite, is respected across the industry for its high end patient-specific 3D modeling capabilities. Just not long ago, Mimics proved itself ready-and-able to assist provide successful thyroplasty surgery to trans women , and has in addition just become the go-to 3D modeling software for the Japan-based healthcare provider Canon Lifecare Solutions.
So it appears safe to say that Materialise is the proper leader for creating additional generally accepted measurement standards for medical-based 3D printing, and their CEO, Fried Vancraen, is calling for an experienced initiative to turn it into this tightened approach. With a globally accepted set of guidelines, the medical 3D printing industry can advantageous persuade physicians, hospitals, and policy makers to adopt this increasingly valuable innovation. With a turn it intoed set of clinical measurement standards for the medical use of 3D printing, government bodies and insurance companies are in addition additional many likely to add medical 3D printing to their approved list of medical procedures and devices, that can allow patients access to the many modern, technologically-driven healthcare solutions.
“There have been several initiatives aimed at properly measuring and validating the clinical benefits of medical 3D Printing, but all have suffered of a lack of coordination and agreed-upon research methodologies,” Vancraen noted. “The fact is, we can just be successful if we take an evidence-based approach across the industry, acting in concert with a set of protocols, methodologies and measurement guidelines. With the proper scientific rigor, our ambition of gaining widespread acceptance of medical 3D Printing can be accomplished additional swiftly, and the patients whom we aim to assist can benefit the many.”
To assist jumpstart the initiative, Materialise can lead the way by studying and designing an evidence-based approach to turn it into these clinical standards, that can include an economical, clinical, engineering and patient-based focus. According to Vancraen, Materialise’s goal is to set the groundwork for additional solid measurements, that can assist validate a variety of medically-driven 3D printing applications, which include anatomical models, patient-specific guides, and implants. With these plans, Materialise can assist ingrain 3D printing innovation actually additional deeply into the medical industry by making additional solid clinical evidence, that should additional incline physicians, hospitals, and other medical organizations to implement 3D printing into their own healthcare services.
Materialise can be presenting this on-going initiative at Building Evidence for 3D Printing Applications in Medicine, an actuallyt hosted by SME and sponsored by Materialise. This actuallyt can follow the RAPID Conference, an yearly 3D printing conference that can take place at the Orange County Convention Center in Orlando, Florida of May 19-20. If you’d like to learn additional of this well-rounded approach to creating advantageous clinical measurement standards for 3D printing, you can either register for the next actuallyt or—for those not in the vicinity of the in-person discussion—request additional information of the Materialise website. Discuss in the Materialise 3D Printing and Clinical Evidence forum over at 3DPB.com.
by admin • March 5, 2017
by admin • November 28, 2016
by admin • November 28, 2016